account_id none on file
legal_name Neumora Therapeutics, Inc.
ticker NMRA
cik 1885522
domain neumoratx.com
linkedin_company_url https://www.linkedin.com/company/neumora/about
entry_point_account_id none on file
name Neumora Therapeutics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 7 executives 0 family 0
why_nownone on file
callsnone on file
filings
As a result of the continued hybrid working environment, we also face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities.
filing / Aug 14, 2026 / receipt
The continuing efforts of the government, insurance companies, managed care organizations, and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect:
filing / Aug 14, 2026 / receipt
Although we announced a reduction in force of approximately 35% in connection with our discontinuation of the development of navacaprant in MDD in June 2026, we will continue to implement and improve our managerial, operational, and financial systems, expand our facilities, and continue to recruit and train additional qualified personnel as we develop our other product candidates.
filing / Aug 14, 2026 / receipt
As a result of the continued hybrid working environment, we also face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities.
filing / May 7, 2026 / receipt
The continuing efforts of the government, insurance companies, managed care organizations, and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect:
filing / May 7, 2026 / receipt
SEC Reporting & Accounting Manager | {"ats": "greenhouse", "city": "Watertown", "state": "MA", "job_id": "6145876004", "remote": false, "category": "finance_ops", "function": "finance", "location": "W
company_statement / Aug 17, 2026 / receipt
Medical Director / Senior Medical Director | {"ats": "greenhouse", "city": null, "state": null, "job_id": "6117128004", "remote": true, "category": "other", "function": "clinical", "location": "Remote
company_statement / Jul 15, 2026 / receipt
executivesnone on file
familynone on file
upcoming
| 2026-11-05 | earnings call | scheduled | ir |
changes
mcp_package_hint
slug neumora-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$